Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China
Puyuan Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Junling Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongge Liang(Guangdong University of Technology), Di Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Du(Harbin Medical University), Xuezhi Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Shan Li(Xinjiang Medical University), Qiang Wang(Xinjiang Medical University), Li Liang(Peking University Third Hospital), Mengzhao Wang(Peking Union Medical College Hospital), Zhaohui Zhang(Peking University), Tao Xin(Harbin Medical University), Yan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shouzheng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 14
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Comprehensive analysis of prognostic immune‐related genes in the tumor microenvironment of cutaneous melanoma
|Journal of Cellular Physiology|2019|111
<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis</p>
|OncoTargets and Therapy|2020|111
PI3K in Cancer: Its Structure, Activation Modes and Role in Shaping Tumor Microenvironment
|Future Oncology|2017|65
Influence of polyvinyl chloride microplastic on chromium uptake and toxicity in sweet potato
|Ecotoxicology and Environmental Safety|2023|59